Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT–mTOR pathway
Miao Deng(Hangzhou Women’s Hospital), Dechun Liu(Henan University of Science and Technology), Jianguang Wang(Jiamusi University), Like Zhang(Henan University of Science and Technology), Yanbin Chen(Henan University of Science and Technology)
Cited by 27
Related Papers
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
|Biomedicine & Pharmacotherapy|2019|200
Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
|Cancer Medicine|2019|197
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
|Journal of Controlled Release|2019|126
Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle
|ACS Applied Materials & Interfaces|2019|98